TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors” page on its ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating ...

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept ...

The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $256,004, and 4 are calls, amounting to ...

NYSE:TEVA opened at $16.18 on Wednesday. The company has a 50-day moving average of $17.79 and a 200-day moving average of $18.21. The firm has a market cap of $18.34 billion, a price-to-earnings ...

BTIG turns bearish on Teva, cuts to Sell; shares down 2% premarket Teva Pharmaceutical Industries (NYSE:TEVA) slips 2% premarket on increased volume on the heels of a downgrade to SELL with a $17 ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other stocks that Jim Cramer discussed 12 months ago. During the latest ...

Deep-pocketed investors have adopted a bullish approach towards Teva Pharmaceutical Indus (NYSE:TEVA), and it's something market players shouldn't ignore. Our tracking of public options records at ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other stocks that Jim Cramer discussed 12 months ago. During the latest ...

Investing.com – Israel stocks were higher after the close on Monday, as gains in the Technology, Banking and Biomed sectors led ...

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel ...